Ridaura (auranofin) is a prescription medication for treating rheumatoid arthritis symptoms. Ridaura may be taken alone or in combination with other drugs.
Ridaura belongs to the DMARDs, or Gold Compounds, class of medicines.
Ridaura’s safety and effectiveness in kids are unknown.
Ridaura can result in serious side effects such as the following:
Get medical attention immediately if you experience any of the symptoms described above.
These are not the only Ridaura adverse effects that might occur. Consult your doctor or pharmacist for further information.
For medical advice on side effects, contact your doctor. You may contact the FDA at 1-800-FDA-1088 to report adverse effects.
Ridaura treats individuals with active classical or definite rheumatoid arthritis who have had an inadequate therapeutic response to or are intolerant of a complete trial of one or more nonsteroidal anti-inflammatory medications.
Ridaura should be used in a complete baseline program that includes nondrug therapy.
Ridaura, unlike anti-inflammatory medications, does not elicit an instant reaction. Although some patients may not improve before six months, therapeutic results may be noticed after three to four months of therapy.
Patients with active synovitis, especially in its early stages, benefit most from Ridaura.
In controlled clinical studies comparing Ridaura to injectable gold, Ridaura had fewer dropouts owing to adverse effects, but injectable gold had fewer dropouts due to insufficient or poor therapeutic efficacy.
Physicians should consider these results when considering whether to utilize Ridaura in individuals who are candidates for chrysotherapy.
Ridaura is usually taken in 6 mg doses daily, either 3 mg twice or 6 mg once daily.
Therapy should not be started at doses of more than 6 mg daily since it is linked with a higher risk of diarrhea.
If the response after six months is insufficient, an increase to 9 mg (3 mg three times a day) may be tolerated.
If the response after a three-month trial of 9 mg daily is insufficient, Ridaura medication should be terminated. The safety of more than 9 mg daily doses has yet to be evaluated.
Concurrent treatment of Ridaura and phenytoin may have elevated phenytoin blood levels, according to a single case report.
It is unknown if Ridaura may harm your unborn child. If you’re pregnant or want to become pregnant, inform your doctor.
You should not breastfeed if you are on Ridaura.
Auranofin may make your skin more sensitive to sunlight, causing a rash or itching.
Avoid tanning beds and direct sunlight. Apply sunscreen (SPF 30 or more) when going outdoors and wear protective clothing.
Call your doctor or the Poison Control Center if someone else has overdosed on Ridaura.
Call 911 if someone falls or stops breathing after taking Ridaura.
A contraindication is a condition that prevents surgery, medicine, or treatment from being utilized to treat the patient since it would be hazardous to the patient otherwise.
This factor might be the presence of a medical condition like high blood pressure or the use of a currently prescribed medicine.
It may also refer to instances where a person takes drugs or receives therapy that might conflict with or adversely interact with other medications.
Drug interactions and contraindications might result in increased health risks and medical disorders. Changes in heart rate or other vital indicators are often among them, along with the following:
Negative medication interactions may sometimes result in serious or life-threatening diseases like heart attacks, seizures, or other scenarios. In certain situations, they may potentially cause long-term harm.
When a medical practitioner offers subpar treatment to a patient, this is referred to as medical malpractice.
All medical practitioners, including pharmacists, are expected to adhere to the same medical care standards as a professional of reasonable competence.
Medical malpractice occurs when a medical provider gives inadequate treatment.
For example, if it is the standard of care to enquire about a patient’s medication history, a doctor is expected to do so. If they do not, they may be held accountable for malpractice if a medication interaction occurs due to failure.
Another case in point is when a pharmacist makes a mistake while providing medicine to a patient. This may take the shape of incorrect dosage size, medicine, or other mistakes resulting in bad drug interaction.
A drug interaction case may also be brought under product liability or defective product statutes.
A defective product is any product, such as medicine, that causes harm to a person due to incorrect labeling, a design flaw, or a manufacturing flaw.
A person who experiences injuries due to drug interactions might sue the medication maker if a faulty product caused the damage.
A prominent example of a drug product fault is when the manufacturer fails to add adequate medication interaction warning labels.
If a person is hurt due to a lack of warnings, there may be grounds for a personal injury claim. In an injury case, damages cover a variety of expenditures, such as lost earnings, medical bills, and other losses.
As previously stated, harmful or unsafe pharmaceuticals are among the most common product liability cases in the United States.
Writing a complaint letter to a pharmaceutical company isn’t always enough. You may need to file legal action for yourself or a loved one, so you must take certain preliminary actions.
If you feel you have a claim regarding harmful medications, you should do the following:
You may then take these things and information to an experienced personal injury lawyer who can assist you in filing a case. If any other individuals have been injured due to unsafe medications, your case may be enhanced; in notable cases, a class action lawsuit may be required.
Lawsuits involving harmful pharmaceuticals are becoming more prevalent because the number of new drugs continually rises each year.
If you need legal advice for your claim, you should contact an experienced class action lawyer in your region. Your attorney can assist you in recovering damages for your losses and guide you through the process.
16 people have successfully posted their cases
